DXCM Q4 2018 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$26B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$338M+52.9% YoY

Gross Profit

$223M65.9% margin

Operating Income

-$165M-48.7% margin

Net Income

-$180M-53.2% margin

EPS (Diluted)

$-0.51

QoQ Revenue Growth

+26.7%

Cash Flow

Operating Cash Flow

$34M

Free Cash Flow

$16M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$1.3B

Stockholders' Equity

$663M

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$338M	$221M	+52.9%
Gross Profit	$223M	$154M	+45.1%
Operating Income	-$165M	$12M	-1471.7%
Net Income	-$180M	-$9M	-1811.7%